Individualizing asthma therapy: Application of biomarkers

Journal of Asthma

Volumn 45, Issue SUPPL. 1, 2008, Pages 29-31

  Szefler, Stanley J ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Asthma; Asthma control; Asthma impairment; Asthma risk; Asthma severity; Biomarkers; Early intervention in asthma; Exhaled nitric oxide; Therapeutics

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; NITRIC OXIDE;

ASTHMA; DISEASE SEVERITY; HUMAN; IMMUNOMODULATION; LUNG LAVAGE; NOSE SECRETION; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SPUTUM; URINE;

ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; HUMANS; INDIVIDUALIZED MEDICINE; NITRIC OXIDE;

EID: 58149083905     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900802570072     Document Type: Review

References (18)

1. National Institutes of Health. National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. August 2007. NIH Publication No. 07-4051. Available at: http://www.nhlbi.nih.gov/guidelines/ asthma/index.htm.
2. Expert Panel Report 3 (EPR-3). Guidelines for the diagnosis and management of asthma: summary report 2007. J Allergy Clin Immunol 2007; 120:S94-S138.
3. Sont JK, Willems LNA, Bel EH, van Krieken JHJM, Vendenbroucke JP, Sterk PJ, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999; 159:1043-1051.
4. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002; 360:1715-1721.
5. Silkoff PE, Carlson M, Bourke T, Katial R, Ogren E, Szefler SJ. The aerocrine exhaled nitric oxide monitoring system niox is cleared by the US food and drug administration for monitoring therapy in asthma. J Allergy Clin Immunol 2004; 114(5):1241-1256.
6. American Thoracic Society. ATS/ERS recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children - 2005. Am J Respir Crit Care Med 2005; 171:912-930.
7. Jones SL, Herbison P, Cowan JO, et al. Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship. Eur Respir J 2002; 20(3):601-608.
8. Silkoff PE, McClean P, Spino M, Erlich L, Slutsky AS, Zamel N. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 2001; 119(5):1322-1328.
9. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 2005; 115:233-242.
10. Martin RJ, Szefler SJ, King TS, Kraft M, Boushey HA, Chinchilli VM, et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 2007; 119:73-80.
11. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide 423 measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352(21):2163-2173.
12. Busse WW, Mitchell H. Addressing issues of asthma in inner city children. J Alergy Clin Immunol 2007; 119:43-49.
13. Jones CA, Clement LT, Morphew T, Kwong KYC, Hanley-Lopez J, Lifson F, et al. Achieving and maintaining asthma control in an urban pediatric disease management program: the Breathmobile Program. J Allergy Clin Immunol 2007; 119:1445-1453.
14. Zefler SJ, Mitchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, et al. Adding exhaled nitric oxide to guideline-based asthma treatment in inner-city adolescents and young adults: a randomized controlled trial. Lancet 2008, in press.
15. Mauad T, Bel EH, Sterk PJ. Asthma therapy and airway remodeling. J Allergy Clin Immunol 2007; 120:997-1009.
16. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007; 120:1233-1244.
17. Chen W, Hershey GK. Signal transducer and activator of transcription signals in allergic disease. J Allergy Clin Immunol 2007; 119:529-541.
18. Schmidt-Weber CB, Akdis M, Akdis CA. Th17 cells in the big picture of immunology. J Allergy Clin Immunol 2007; 120:247-254.